Clinical data | |
---|---|
Other names | Iodopindolol; 3-Iodopindolol |
Identifiers | |
IUPAC name
| |
CAS Number | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H19IN2O2 |
Molar mass | 374.222 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Iodopindolol is a beta-adrenergic selective antagonist tagged with radioactive iodine-125. It has been used to map beta receptors in cellular experiments.
See also
References
- Ezrailson EG, Garber AJ, Munson PJ, Swartz TL, Birnbaumer L, Entman ML (1981). "iodopindolol: a new beta adrenergic receptor probe". Journal of Cyclic Nucleotide Research. 7 (1): 13–26. PMID 6265511.
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |
This nuclear medicine article is a stub. You can help Misplaced Pages by expanding it. |